Abstract
5‐Fluorouracil is an antineoplastic antimetabolite responsible for a variety of cutaneous reactions. We report a case of chronic cutaneous lupus flare related to systemic 5‐fluorouracil administration for breast cancer in a patient with documented history of chronic cutaneous lupus.